
Varex Imaging (VREX) Stock Forecast & Price Target
Varex Imaging (VREX) Analyst Ratings
Bulls say
Varex Imaging Corp experienced robust growth in both its Medical and Industrial segments, with the Industrial segment achieving a record revenue of $76.8 million, reflecting a year-over-year increase of 25.3%, bolstered by strong cargo inspection system shipments. The company is poised for future growth, particularly with indications of stabilizing demand in China and a projected increase in orders for CT systems, along with successful manufacturing expansions in India which are expected to enhance revenue streams in FY2026. Furthermore, Varex's strategic initiatives like a local-for-local manufacturing approach and advancements in photon counting CT technology are likely to contribute positively to its operational efficiency and market positioning, supporting a favorable outlook for the stock.
Bears say
Varex Imaging Corp faces potential challenges due to increasing tariffs between China and the U.S., which could adversely affect approximately 15% of its total revenues. Additionally, ongoing anti-corruption measures in China are leading to difficulties in sales within the region, and rising costs associated with importing materials further complicate operations. Despite having $155 million in cash and marketable securities, this represents a significant year-over-year decline of $58 million, raising concerns about liquidity and financial stability moving forward.
This aggregate rating is based on analysts' research of Varex Imaging and is not a guaranteed prediction by Public.com or investment advice.
Varex Imaging (VREX) Analyst Forecast & Price Prediction
Start investing in Varex Imaging (VREX)
Order type
Buy in
Order amount
Est. shares
0 shares